share_log

Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics

Dow Jones Newswires ·  2020/10/13 01:24

*DJ Nestle Now Has Around 84% of Aimmune Therapeutics Shares

(MORE TO FOLLOW) Dow Jones Newswires

October 13, 2020 01:18 ET (05:18 GMT)

*DJ Nestle's Subsidiary SPN MergerSub Offered $34.5 for Each Aimmune Therapeutics Share Not Owned by Nestle

(MORE TO FOLLOW) Dow Jones Newswires

October 13, 2020 01:21 ET (05:21 GMT)

*DJ Nestle: Minimum Tender Condition Has Been Satisfied

(MORE TO FOLLOW) Dow Jones Newswires

October 13, 2020 01:22 ET (05:22 GMT)

*DJ Nestle Wants to Merge SPN MergerSub Subsidiary With Aimmune Therapeutics

(MORE TO FOLLOW) Dow Jones Newswires

October 13, 2020 01:24 ET (05:24 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする